Funded Tech Companies
T-CURX
T-CURX, based in Würzburg, received equity investments through BioMed Ventures, HighLight Capital and i&i Biotech Fund.
Company Overview
Company Name
T-CURX
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Friedrich-Bergius-Ring 15
Würzburg, 97076
Germany
Würzburg, 97076
Germany
Phone
Website
Email Address
Company Background Information
Overview
T-CURX is a Biotech company, spun-out from the University Clinics Würzburg, Germany, developing first- and best-in-class personalized immunotherapies on the basis of CAR-T cells. CAR-T cells are a transformative, one-shot, chemotherapy-free targeted and personalized cancer treatment. T-CURX has exclusive licenses for proprietary technologies and CAR-T product opportunities developed in the laboratory of Prof. M. Hudecek, Würzburg, Germany one of the leading European clinical CAR-T cell laboratories.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/17/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ulf Grawunder
Company Investors
- BioMed Ventures
- HighLight Capital
- i&i Biotech Fund
- Bayern Kapital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs